CCR4 chemokine antagonist (Aurigene Oncology)

N/A

Report date: 2025/06/11 10:50:27
NME

Base Information

Drug NameCCR4 chemokine antagonist (Aurigene Oncology)
Drug Alias NameAU-CCR4iTreg modulator (Aurigene Oncology)
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 4 antagonistsImmunostimulantsRegulatory T-lymphocytes inhibitors
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Oncology Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A